Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.59%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information
Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQHERON THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
HRTX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.88M | 2.59% | $ 149.69M |
| 3/31/2025 | $ -2.95M | -1.99% | $ 148.52M |
| 12/31/2024 | $ -8.61M | -5.96% | $ 144.28M |
| 9/30/2024 | $ -24.84M | -18.03% | $ 137.74M |
| 6/30/2024 | $ -44.85M | -32.89% | $ 136.36M |
| 3/31/2024 | $ -77.58M | -58.73% | $ 132.1M |
| 12/31/2023 | $ -107.16M | -84.35% | $ 127.04M |
| 9/30/2023 | $ -115.89M | -94.35% | $ 122.84M |
| 6/30/2023 | $ -132.81M | -112.59% | $ 117.96M |
| 3/31/2023 | $ -147.18M | -129.3% | $ 113.83M |
Key Performance Insights, Last 5 Years
- HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -219.18%.
- Over the past 5 years, HERON THERAPEUTICS INC's average EBITDA % has been -147.22%.
- The median EBITDA % for HERON THERAPEUTICS INC during this period was -147.45%
- HERON THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 2.59%.
- The lowest EBITDA % recorded by HERON THERAPEUTICS INC in the same timeframe -280.52%
HERON THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for HERON THERAPEUTICS INC is calculated as follows: EBITDA [ $ -226M ] / Revenues [ $ 103.12M ]
(=) EBITDA % [ -219.18% ] HRTX - EBITDA Margin, Last 5 years
-280.52%
Minimum
Jun 30, 2021
2.59%
Maximum
Jun 30, 2025
-147.22%
Average
-147.45%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |